E Fund Management Co., Ltd. Vaxart, Inc. Transaction History

E Fund Management Co., Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.09 - $4.5 $22,785 - $49,059	10,902 Added 17.69%	72,516 $158,000
Q2 2022 Aug 15, 2022	BUY	$2.7 - $5.28 $31,387 - $61,380	11,625 Added 23.26%	61,614 $216,000
Q1 2022 May 12, 2022	BUY	$4.29 - $6.64 $95,435 - $147,713	22,246 Added 80.19%	49,989 $252,000
Q4 2021 Feb 11, 2022	BUY	$5.77 - $7.96 $45,813 - $63,202	7,940 Added 40.09%	27,743 $174,000
Q3 2021 Nov 12, 2021	SELL	$6.67 - $9.8 $5,135 - $7,546	-770 Reduced 3.74%	19,803 $157,000
Q1 2021 May 12, 2021	BUY	$5.64 - $23.33 $116,031 - $479,968	20,573 New	20,573 $124,000

107

37.7M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $86M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.